These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 427324)

  • 21. Injections of deuterated tryptamine into the nucleus accumbens of the rat: effects on locomotor activity and monoamine metabolism.
    Marien MR; Gerber R; Boyar WC; Altar CA
    Neuropharmacology; 1987 Oct; 26(10):1481-8. PubMed ID: 3683763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of some antipsychotic drugs, D-amphetamine, and reserpine on the concentration and rate of accumulation of tryptamine and 5-hydroxytryptamine in the mouse striatum.
    Juorio AV
    Can J Physiol Pharmacol; 1982 Mar; 60(3):376-80. PubMed ID: 6122494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB; Olsen AK; Pedersen K; Cumming P
    Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the biogenic amines in the reversal of cycloheximide-induced amnesia.
    Quartermain D; Botwinick CY
    J Comp Physiol Psychol; 1975 Jan; 88(1):386-401. PubMed ID: 235572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.
    Ross SB; Ogren SO; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):337-52. PubMed ID: 579062
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
    Breese GR; Cooper BR; Mueller RA
    Br J Pharmacol; 1974 Oct; 52(2):307-314. PubMed ID: 4155993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pilocarpine in combination with monoamine oxidase inhibitors, imipramine or desmethylimipramine on oestrous behaviour in female rats.
    Lindström LH
    Psychopharmacologia; 1970; 17(2):160-8. PubMed ID: 5462745
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings: Influence of MAO-inhibitors on the intestinal absorption of biogenic amines.
    Huebers H; Huebers E; Huebers U; Rummel W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R36. PubMed ID: 4276566
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of monoamine oxidase inhibitors and amphetamine on hypothermia produced by halothane.
    Feldberg W; Lang WJ
    Br J Pharmacol; 1970 Jan; 38(1):181-91. PubMed ID: 4391731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.
    Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F
    Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the pharmacology of d-amphetamine on maximal electroconvulsive seizure in young chicks.
    Osuide G; Wambebe C; Ngur D
    Psychopharmacology (Berl); 1983; 81(2):119-21. PubMed ID: 6415741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphetamine-induced changes in body temperature and glycogen content of the encephalon in the chicken.
    Hevor TK; Lehr PR; Gayet J
    Experientia; 1975 Jun; 31(6):674-6. PubMed ID: 1140291
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the effects of beta-phenylethylamine and d-amphetamine on rat isolated atria.
    Pesce G; Adler-Graschinsky E
    J Pharmacol Exp Ther; 1983 Oct; 227(1):205-14. PubMed ID: 6555238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of chronic administration and withdrawal of amphetamine on cerebral dopamine receptor sensitivity.
    Jenner P; Pycock C; Marsden CD
    Psychopharmacology (Berl); 1978 Jul; 58(2):131-6. PubMed ID: 98779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential activity of enantiomers of amphetamine in rats.
    Maickel RP; Light KE; Zabik JE
    Neuropharmacology; 1982 Dec; 21(12):1323-7. PubMed ID: 6218425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
    J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of desipramine and pargyline on brain gamma-aminobutyric acid.
    Patel GJ; Schatz RP; Constantinides SM; Lal H
    Biochem Pharmacol; 1975 Jan; 24(1):57-60. PubMed ID: 1122262
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.